Cortexyme, Inc. (CRTX) Social Stream



Cortexyme, Inc. (CRTX): $10.00

0.01 (+0.10%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CRTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 465

in industry

Cortexyme Inc (CRTX) Price Targets From Analysts

Use the tables below to see what analysts covering Cortexyme Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
3 $150 $17 $65.666 $11.63 464.63%
4 $150 $17 $54.25 $11.63 366.47%

The Trend in the Analyst Price Target


Over the past 18 months, CRTX's average price target has gone down $4.15.

CRTX reports an average of 88.69% for its upside potential over the past 18 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-12 3 150 17 65.666 14.26 360.49%
2021-11-12 4 150 17 65.666 14.26 360.49%
2021-11-12 3 150 17 54.250 14.26 280.43%
2021-11-12 4 150 17 54.250 14.26 280.43%
2021-01-09 4 213 14 75.750 NA NA%
2021-01-09 7 213 14 75.750 NA NA%
2020-06-01 NA 84 14 58.400 NA NA%

CRTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 2 0 0 0 0 3

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • CRTX has a lower variance in analysts' estimates than -99.61% of all US stocks.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, Cortexyme Inc's upside potential (average analyst target price relative to current price) is higher than 197.52% of them.
  • In the context of stocks in the mid market cap category, Cortexyme Inc's number of analysts covering the stock is higher than 25.63% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Cortexyme Inc's average analyst price target is higher than 152.45% of them.

In the Pharmaceutical Products industry, BYSI, CEMI and RYTM are the three stocks most similar to Cortexyme Inc regarding the price target and analyst recommendation information presented here.

Is CRTX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.626 seconds.